A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
about
A molecular map of mesenchymal tumors.Clinically Relevant Molecular Subtypes in LeiomyosarcomaDiagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.A Marfan syndrome gene expression phenotype in cultured skin fibroblasts.Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors.The evolutionary history of lethal metastatic prostate cancer.Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue SarcomaComparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma.The role of microarray technologies in the study of soft tissue tumours.Adult human sarcomas. II. Medical oncology.Rit subfamily small GTPases: regulators in neuronal differentiation and survival.Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.Gene expression signatures of primary and metastatic uterine leiomyosarcoma.Proteomic analysis of soft tissue sarcoma.Role of genetic and molecular profiling in sarcomas.Gene expression profiling identifies distinct molecular subgroups of leiomyosarcoma with clinical relevance.The Scandinavian Sarcoma Group: 30 years' experience.Gene expression identifies heterogeneity of metastatic propensity in high-grade soft tissue sarcomas.Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways.The Genomic Grade Index predicts post-operative clinical outcome in patients with soft tissue sarcoma.[Sarcoma gene signatures].Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes.
P2860
Q24814030-E9FD1B29-0A84-478A-B525-77A79DB1725CQ30300155-20BA742B-8C47-4B17-90D2-0EC6261417A5Q33278631-51E1923C-287A-4FB6-B0B7-9BDC2485B868Q33298689-13DFA0F0-38F3-4B0D-A4D1-FFA1C870CF3CQ33647672-DA915F52-7A0E-44B8-927A-EB4DA2E6068AQ33655346-1BBDE64B-A5A2-4361-8F6F-BF1D5FEEED77Q35548366-6B07412E-A493-43C7-A74F-B83AFC2A24E8Q35616920-A6D1D6E0-BD58-4D0D-B49B-E1058DCD9D37Q36167331-00854F56-5529-433F-A647-522D116D655CQ36344271-F8628398-2C52-4D29-B02A-A43D2E83D79BQ36731430-219F3A2F-15F8-4733-8B9B-7153F9850C73Q37173904-15D32311-A1E2-4909-8211-45A5D09B9813Q37468623-8224F6C9-7170-4ABF-BF7B-08244A29363AQ37662836-77189948-4D0E-431F-AF1F-EA2A539062E6Q37850740-517C3922-9777-4456-BAEF-9A0A615A06EBQ38458016-623FC47B-4057-49BE-8FAD-4379400085A4Q39410427-A2517FFA-9D60-4239-B385-B38C9FF4E354Q43589203-596D4A01-97FA-4D92-900A-CC7623294F75Q45795166-03A17726-DC14-4E53-9E28-028F23CFBF75Q46658880-A5E8E9FD-41B4-4C26-A9D3-14C106BE5A57Q47720588-FD566DA1-065F-4E45-B2F3-E76F70E64660Q54389752-D911CBB8-EC63-4A17-9AD8-FB7CFCD24C2AQ55400673-F13B361D-4B95-4630-B6A5-C2EDCB10C621
P2860
A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
@en
type
label
A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
@en
prefLabel
A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
@en
P2093
P1433
P1476
A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
@en
P2093
Alison Falconer
Colin S Cooper
Cyril Fisher
D Chas Mangham
Ian Judson
J Meirion Thomas
Janet Shipley
Jeremy Clark
Megan John
Penny Flohr
P304
P356
10.1158/0008-5472.CAN-04-1673
P407
P577
2004-10-01T00:00:00Z